Dr. Lal PathLabs Limited
LALPATHLAB
주식 순위
#4525
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
주가
$20.35
마지막 동기화: 2026-10-19
시가총액
$3.40B
변동 (1일)
-0.86%
변동 (1년)
14.21%
국가
IN
거래 Dr. Lal PathLabs Limited (LALPATHLAB)
카테고리
Healthcare
Dr. Lal PathLabs Limited (LALPATHLAB)의 매출
Jun 2026 기준 매출 TTM: $319.03M
Dr. Lal PathLabs Limited의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $319.03M입니다. 2024년에 회사는 $267.04M의 수익을 올렸으며 이는 2023년의 $245.42M 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Dr. Lal PathLabs Limited의 수익 기록 (2011 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $319.03M | 10.85% |
| 2025 | $287.79M | 7.77% |
| 2024 | $267.04M | 8.81% |
| 2023 | $245.42M | -10.75% |
| 2022 | $274.99M | 27.30% |
| 2021 | $216.01M | 22.32% |
| 2020 | $176.59M | 1.90% |
| 2019 | $173.30M | 6.76% |
| 2018 | $162.33M | 15.38% |
| 2017 | $140.69M | 17.79% |
| 2016 | $119.44M | 13.00% |
| 2015 | $105.71M | -3.94% |
| 2014 | $110.04M | 32.38% |
| 2013 | $83.13M | 23.17% |
| 2012 | $67.49M | 26.76% |
| 2011 | $53.24M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $46.34B | 14,424.25% |
US
|
|
| $25.11B | 7,769.91% |
US
|
|
| $2.71B | 748.55% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 2,210.79% |
US
|
